| 000 | 01389 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513191740.0 | ||
| 264 | 0 | _c19991105 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0022-0795 | ||
| 024 | 7 |
_a10.1677/joe.0.1620321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolly, J M | |
| 245 | 0 | 0 |
_aGrowth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? _h[electronic resource] |
| 260 |
_bThe Journal of endocrinology _cSep 1999 |
||
| 300 |
_a321-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aGrowth Hormone _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xepidemiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aGunnell, D J | |
| 700 | 1 | _aDavey Smith, G | |
| 773 | 0 |
_tThe Journal of endocrinology _gvol. 162 _gno. 3 _gp. 321-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1677/joe.0.1620321 _zAvailable from publisher's website |
| 999 |
_c10424746 _d10424746 |
||